Pulegone Prevents Hypertension through Activation of Muscarinic Receptors and Cyclooxygenase Pathway in L-NAME-Induced Hypertensive Rats
The current study was designed to determine pulegone’s antihypertensive and vasoprotective activity in L-NAME-induced hypertensive rats. Firstly, the hypotensive dose-response relationship of pulegone was evaluated in normotensive anesthetized rats using the invasive method. Secondly, the mechanism...
Saved in:
| Main Authors: | Muryam Abdul Razzaq, Waqas Younis, Muhammad Nasir Hayat Malik, Tariq G. Alsahli, null Alamgeer, Shah Jahan, Roma Ehsan, Arquimedes Gasparotto Junior, Asifa Bashir |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Cardiovascular Therapeutics |
| Online Access: | http://dx.doi.org/10.1155/2023/8166840 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The potential of volatile oil farnesol as a new treatment for hypertension and improvement of vascular function in hypertensive rats
by: Roma Ehsan, et al.
Published: (2026-03-01) -
Pulegone Application Trends: Exploration of Uses Based on Leading Patent Applicants
by: Reda El Boukhari, et al.
Published: (2024-04-01) -
Vasodilator Effects of Quercetin 3-O-Malonylglucoside Are Mediated by the Activation of Endothelial Nitric Oxide Synthase and the Opening of Large-Conductance Calcium-Activated K<sup>+</sup> Channels in the Resistance Vessels of Hypertensive Rats
by: Maria Luiza Fidelis da Silva, et al.
Published: (2025-07-01) -
Synergistic catalysis by AlB doped Pd/AC for selective conversion of pulegone to thymol: Mechanistic elucidation and process intensification
by: Prashant Kumar, et al.
Published: (2025-08-01) -
Is muscarinic receptor agonist effective and tolerant for schizophrenia?
by: Xiaonan Guo, et al.
Published: (2025-04-01)